ALL-RIC

Trial description
A comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission
Contact name
Dr Ben Uttenthal
Trial start date
Friday, March 15, 2019
Trial end date
Wednesday, September 30, 2020
Trial tumour type
Haematological
Show on Radiotherapy
No